Jeffrey Z.  Mann net worth and biography

Jeffrey Mann Biography and Net Worth

General Counsel and Head of Business Development of Embecta

Jeff Mann serves as the General Counsel and Head of Business Development for embecta. Jeff brings 22 years of medical device and law firm experience to embecta, including leadership in M&A, securities, corporate governance, intellectual property, commercial transactions, compliance and litigation, and he has deep roots in the medical, pharmaceutical and biotechnology sectors.

Most recently, he served as General Counsel and Corporate Secretary of Cantel Medical Corp., a global medical products company focused on infection prevention products, where he was responsible for the global legal, compliance, and environmental health and safety teams. He also led several business development projects, including the eventual sale of Cantel to Steris plc for $4.6 billion. Simultaneously, he held a year-long assignment as global leader of Cantel’s R&D team, managing a team of 130 associates based in Germany, Italy, the United Kingdom and the U.S.

Prior to Cantel, he spent 14 years with Boston Scientific Corporation in roles of increasing responsibility, including M&A, venture capital investments, SEC and corporate governance patent strategy, litigation, and business unit support for the $3 billion MedSurg group. He also served on the Board of Directors of Preventice Solutions and as Chair of its Compensation Committee.

Jeff holds a Bachelor of Science in Civil and Environmental Engineering from Lafayette College in Easton, PA, and a J.D. from Boston College Law School, magna cum laude.

What is Jeffrey Z. Mann's net worth?

The estimated net worth of Jeffrey Z. Mann is at least $646.29 thousand as of August 10th, 2023. Mr. Mann owns 55,333 shares of Embecta stock worth more than $646,289 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Mann may own. Additionally, Mr. Mann receives a salary of $959,450.00 as General Counsel and Head of Business Development at Embecta. Learn More about Jeffrey Z. Mann's net worth.

How old is Jeffrey Z. Mann?

Mr. Mann is currently 52 years old. There are 7 older executives and no younger executives at Embecta. The oldest executive at Embecta is Ms. Jean M. Casner, Senior VP & Chief Human Resources Officer, who is 66 years old. Learn More on Jeffrey Z. Mann's age.

What is Jeffrey Z. Mann's salary?

As the General Counsel and Head of Business Development of Embecta Corp., Mr. Mann earns $959,450.00 per year. There are 2 executives that earn more than Mr. Mann. The highest earning executive at Embecta is Mr. Devdatt Kurdikar, President, CEO & Director, who commands a salary of $2,200,000.00 per year. Learn More on Jeffrey Z. Mann's salary.

How do I contact Jeffrey Z. Mann?

The corporate mailing address for Mr. Mann and other Embecta executives is , , . Embecta can also be reached via phone at 201-847-6880 and via email at [email protected]. Learn More on Jeffrey Z. Mann's contact information.

Has Jeffrey Z. Mann been buying or selling shares of Embecta?

Jeffrey Z. Mann has not been actively trading shares of Embecta over the course of the past ninety days. Most recently, on Thursday, August 10th, Jeffrey Z. Mann bought 4,700 shares of Embecta stock. The stock was acquired at an average cost of $21.67 per share, with a total value of $101,849.00. Following the completion of the transaction, the senior vice president now directly owns 55,333 shares of the company's stock, valued at $1,199,066.11. Learn More on Jeffrey Z. Mann's trading history.

Who are Embecta's active insiders?

Embecta's insider roster includes Jacob Elguicze (SVP, Chief Financial Officer), Devdatt Kurdikar (CEO), Jeffrey Mann (General Counsel and Head of Business Development), and David Melcher (Director). Learn More on Embecta's active insiders.

Are insiders buying or selling shares of Embecta?

During the last year, Embecta insiders bought shares 1 times. They purchased a total of 10,000 shares worth more than $106,000.00. During the last year, insiders at the sold shares 1 times. They sold a total of 3,100 shares worth more than $50,778.00. The most recent insider tranaction occured on May, 23rd when Director David F Melcher bought 10,000 shares worth more than $106,000.00. Insiders at Embecta own 0.4% of the company. Learn More about insider trades at Embecta.

Information on this page was last updated on 5/23/2025.

Jeffrey Z. Mann Insider Trading History at Embecta

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/10/2023Buy4,700$21.67$101,849.0055,333View SEC Filing Icon  
See Full Table

Jeffrey Z. Mann Buying and Selling Activity at Embecta

This chart shows Jeffrey Z Mann's buying and selling at Embecta by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Embecta Company Overview

Embecta logo
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Read More

Today's Range

Now: $11.68
Low: $11.50
High: $12.03

50 Day Range

MA: $13.73
Low: $11.68
High: $14.71

2 Week Range

Now: $11.68
Low: $9.20
High: $21.23

Volume

923,892 shs

Average Volume

545,451 shs

Market Capitalization

$683.40 million

P/E Ratio

7.17

Dividend Yield

5.02%

Beta

1.1